AU5552400A - Treatment of cancer - Google Patents

Treatment of cancer

Info

Publication number
AU5552400A
AU5552400A AU55524/00A AU5552400A AU5552400A AU 5552400 A AU5552400 A AU 5552400A AU 55524/00 A AU55524/00 A AU 55524/00A AU 5552400 A AU5552400 A AU 5552400A AU 5552400 A AU5552400 A AU 5552400A
Authority
AU
Australia
Prior art keywords
cancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55524/00A
Inventor
Jurgen Groet
Dean Nizetic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
School of Pharmacy University of London
Original Assignee
School of Pharmacy University of London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9914589.8A external-priority patent/GB9914589D0/en
Priority claimed from GB0008161A external-priority patent/GB0008161D0/en
Application filed by School of Pharmacy University of London filed Critical School of Pharmacy University of London
Publication of AU5552400A publication Critical patent/AU5552400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU55524/00A 1999-06-22 2000-06-22 Treatment of cancer Abandoned AU5552400A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9914589 1999-06-22
GBGB9914589.8A GB9914589D0 (en) 1999-06-22 1999-06-22 Diagnosis and treatment of alzheimers diease
GB0008161A GB0008161D0 (en) 2000-04-03 2000-04-03 Treatment of cancer
GB0008161 2000-04-03
PCT/GB2000/002446 WO2000079267A2 (en) 1999-06-22 2000-06-22 Use of hte ubiquitin specific protease usp25 in the treatment, prophylaxis and diagnosis of cancer

Publications (1)

Publication Number Publication Date
AU5552400A true AU5552400A (en) 2001-01-09

Family

ID=26244028

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55524/00A Abandoned AU5552400A (en) 1999-06-22 2000-06-22 Treatment of cancer

Country Status (2)

Country Link
AU (1) AU5552400A (en)
WO (1) WO2000079267A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6709839B1 (en) * 1999-09-24 2004-03-23 Rigel Pharmaceuticals, Inc. SYK-UBP proteins, compositions and methods of use
WO2001046443A2 (en) * 1999-12-23 2001-06-28 Incyte Genomics, Inc. Proteases
WO2002055536A2 (en) 2001-01-12 2002-07-18 California Institute Of Technology Regulation of target protein activity through modifier proteins
US7122332B2 (en) 2001-03-29 2006-10-17 Rigel Pharmaceuticals, Inc. Modulators of leukocyte activation, compositions and methods of use
US7939251B2 (en) 2004-05-06 2011-05-10 Roche Molecular Systems, Inc. SENP1 as a marker for cancer
WO2006002453A2 (en) * 2004-07-07 2006-01-12 Biodevelops Pharma Entwicklung Gmbh Use of a deubiquitinating compound for enhancing the expression of membrane proteins on the cell surface

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999046289A1 (en) * 1998-03-12 1999-09-16 Human Genome Sciences, Inc. 31 human secreted proteins

Also Published As

Publication number Publication date
WO2000079267A3 (en) 2001-02-15
WO2000079267A2 (en) 2000-12-28

Similar Documents

Publication Publication Date Title
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU3791601A (en) Treatment of coal
AU2495200A (en) Compositions and methods for the treatment of tumor
EP1176964B8 (en) Uses of et743 for treating cancer
AUPQ923100A0 (en) Treatment of prostate cancer
AU3896900A (en) Treatment of pain
AU1916601A (en) Oncolytic combinations for the treatment of cancer
AU5547000A (en) Novel treatment
AU1916501A (en) Oncolytic combinations for the treatment of cancer
AU7636800A (en) Improved ricin-like toxins for treatment of cancer
AU4556800A (en) Novel treatment
AU5552400A (en) Treatment of cancer
AUPQ367699A0 (en) Treatment of cancer
AU1917101A (en) Oncolytic combinations for the treatment of cancer
AU1595001A (en) Oncolytic combinations for the treatment of cancer
AU3760900A (en) Treatment of menstrual function
AU1595101A (en) Oncolytic combinations for the treatment of cancer
AU2001257325A1 (en) Cancer treatment
AU1618901A (en) Treatment of rosacea
AU1405001A (en) Treatment of diseases
GB9819999D0 (en) Treatment of cancer
AU2001289127A1 (en) Tumor treatment
AU4598100A (en) Treating cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase